Log In
Print
BCIQ
Print
Print this Print this
 

CH5183284, Debio 1347, FF284

  Manage Alerts
Collapse Summary General Information
Company Chugai Pharmaceutical Co. Ltd.
DescriptionInhibitor of fibroblast growth factor receptor (FGFR) receptors 1, 2 and 3
Molecular Target Fibroblast growth factor (FGF) receptor 1 (FGFR1) (CD331) ; Keratinocyte growth factor (KGF) receptor (KGFR) (FGFR2) (CD332)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors; Treat solid tumors
Regulatory Designation
Partner Debiopharm Group

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today